Download Files:
Products Details
Product Description
– Relugolix-d6 is a deuterated compound of Relugolix. Relugolix has a CAS number of 737789-87-6. Relugolix is an orally available, non-peptide gonadotropin-releasing hormone (GnRH or luteinizing hormone-releasing hormone (LHRH)) antagonist, with potential antineoplastic activity. Relugolix competitively binds to and blocks the GnRH receptor in the anterior pituitary gland, which both prevents GnRH binding to the GnRH receptor and inhibits the secretion and release of both luteinizing hormone (LH) and follicle stimulating hormone (FSH). In males, the inhibition of LH secretion prevents the release of testosterone from Leydig cells in the testes. Since testosterone is required to sustain prostate growth, reducing testosterone levels may inhibit hormone-dependent prostate cancer cell proliferation.
Web ID
– TMIJ-0268
Storage Temperature
– -20℃
Shipping
– Blue Ice
Molecular Formula
– C29H21D6F2N7O5S
Molecular Weight
– C29H21D6F2N7O5S
SMILES
– C1C(F)=C(CN2C(N(C3N=NC(OC)=CC=3)C(=O)C3C(CN(C([2H])([2H])[2H])C([2H])([2H])[2H])=C(SC=32)C2=CC=C(NC(NOC)=O)C=C2)=O)C(F)=CC=1
Product type
– Isotope products
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
